Pfizer, Apotex End Patent Fight Over Generic Lipitor

Law360, New York (March 1, 2012, 6:24 PM EST) -- An Illinois federal judge on Thursday dismissed Pfizer Inc.’s patent infringement suit against Canadian drugmaker Apotex Inc. over a generic version of anti-cholesterol drug Lipitor after the parties announced they had reached a settlement.

U.S. District Judge Edmond E. Chang approved a joint motion to dismiss without prejudice claims and counterclaims over Apotex’s abbreviated new drug application for generic Lipitor. Terms of the settlement agreement were not disclosed. 

New York-based Pfizer lodged complaints in Illinois and Delaware alleging patent infringement in December 2008, in response to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.